Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

2485 ARTÍCULOS , VIENDO DEL 586 AL 600

Recent Advances in Drug Development for Alzheimer's Disease: A Comprehensive Review

Xing H, Yue S, Qin R, Du X, Wu Y, Zhangsun D, Luo S.

Int J Mol Sci. 2025 Apr 21;26(8):3905. doi: 10.3390/ijms26083905.

Exploring the complex dimensions of Alzheimer's disease: The promising role of circular RNAs and their potential contributions

Harsij Z, Mehrabi Z, Davoudi N.

Gene. 2025 Aug 10;960:149549. doi: 10.1016/j.gene.2025.149549. Epub 2025 May 6.

NGF-based cholinergic therapies in Alzheimer disease

Mitra S, Gera R, Eriksdotter M.

Handb Clin Neurol. 2025;211:123-135. doi: 10.1016/B978-0-443-19088-9.00007-X.

Evaluation of Illumina and Oxford Nanopore Sequencing for the Study of DNA Methylation in Alzheimer's Disease and Frontotemporal Dementia

Pagano L, Lagrotteria D, Facconi A, Saraceno C, Longobardi A, Bellini S, Ingannato A, Bagnoli S, Ducci T, Mingrino A, Laganà V, Paparazzo E, Borroni B, Maletta R, Nacmias B, Montesanto A, Ghidoni R.

Int J Mol Sci. 2025 Apr 28;26(9):4198. doi: 10.3390/ijms26094198.

Implications of Mucin-Type O-Glycosylation in Alzheimer's Disease

Vela Navarro N, De Nadai Mundim G, Cudic M.

Molecules. 2025 Apr 24;30(9):1895. doi: 10.3390/molecules30091895.

RAGE-Mediated Effects of Formaldehyde in Alzheimer's Disease

Mikhailov IG, Mikhailova MS, Shuvaev AN, Gorina YV, Belozor OS.

Biochemistry (Mosc). 2025 Mar;90(3):334-348. doi: 10.1134/S0006297924604593.

[Expert consensus on disease-modifying therapy for Alzheimer's disease (2025 edition)]

Neurologist Branch, Chinese Medical Doctor Association; Expert Group for Expert Consensus on Disease-Modifying Therapy for Alzheimer′s Disease.

Zhonghua Yi Xue Za Zhi. 2025 May 20;105(19):1492-1502. doi: 10.3760/cma.j.cn112137-20250304-00512. Epub 2025 Mar 18.

Decoding the role of glucocorticoid-regulated kinase 1 in Alzheimer's disease: a promising path toward novel therapeutic strategies

Mittal Y, Kumar P, Joshi K, Aran KR.

Inflammopharmacology. 2025 Jun;33(6):2997-3013. doi: 10.1007/s10787-025-01777-z. Epub 2025 May 15.

Anti-Amyloid Agents: A Self-Fulfilling prophecy

Giannakis A, Konitsiotis S.

J Clin Neurosci. 2025 Jul;137:111338. doi: 10.1016/j.jocn.2025.111338. Epub 2025 May 19.

Glycation in Alzheimer's Disease and Type 2 Diabetes: The Prospect of Dual Drug Approaches for Therapeutic Interventions

Ayoub S, Arabi M, Al-Najjar Y, Laswi I, Outeiro TF, Chaari A.

Mol Neurobiol. 2025 Nov;62(11):14859-14882. doi: 10.1007/s12035-025-05051-9. Epub 2025 May 22.

Experimental modeling of Alzheimer's disease: Translational lessons from cross-taxon analyses

Yenkoyan KB, Kotova MM, Apukhtin KV, Galstyan DS, Amstislavskaya TG, Strekalova T, de Abreu MS, Chavushyan VA, Lim LW, Yang L, Rosemberg DD, Kalueff AV.

Alzheimers Dement. 2025 May;21(5):e70273. doi: 10.1002/alz.70273.

Inflammasome-Mediated Neuroinflammation: A Key Driver in Alzheimer's Disease Pathogenesis

McGroarty J, Salinas S, Evans H, Jimenez B, Tran V, Kadavakollu S, Vashist A, Atluri V.

Biomolecules. 2025 May 7;15(5):676. doi: 10.3390/biom15050676.

A 2025 update on treatment strategies for the Alzheimer's disease spectrum

Wu CK, Fuh JL.

J Chin Med Assoc. 2025 Jul 1;88(7):495-502. doi: 10.1097/JCMA.0000000000001252. Epub 2025 May 30.

From genetic roots to recent advancements in gene therapy targeting amyloid beta in Alzheimer's disease

Peyvand P, Allami P, Rezaei N.

Rev Neurosci. 2025 May 30;36(8):825-848. doi: 10.1515/revneuro-2025-0025. Print 2025 Dec 17.

Therapeutic Advances in Alzheimer’s Disease: Integrating Natural, Semi-Synthetic, and Synthetic Drug Strategies

Chauhan BS, Singh YP, Poeggeler B, Singh SK.

Curr Alzheimer Res. 2025;22(9):661-677. doi: 10.2174/0115672050366727250513061730.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias